These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
190 related articles for article (PubMed ID: 24519928)
1. Cyclooxygenase-2 in endothelial and vascular smooth muscle cells restrains atherogenesis in hyperlipidemic mice. Tang SY; Monslow J; Todd L; Lawson J; Puré E; FitzGerald GA Circulation; 2014 Apr; 129(17):1761-9. PubMed ID: 24519928 [TBL] [Abstract][Full Text] [Related]
2. Targeted deletions of cyclooxygenase-2 and atherogenesis in mice. Hui Y; Ricciotti E; Crichton I; Yu Z; Wang D; Stubbe J; Wang M; Puré E; FitzGerald GA Circulation; 2010 Jun; 121(24):2654-60. PubMed ID: 20530000 [TBL] [Abstract][Full Text] [Related]
3. Deletion of microsomal prostaglandin E synthase-1 augments prostacyclin and retards atherogenesis. Wang M; Zukas AM; Hui Y; Ricciotti E; Puré E; FitzGerald GA Proc Natl Acad Sci U S A; 2006 Sep; 103(39):14507-12. PubMed ID: 16973753 [TBL] [Abstract][Full Text] [Related]
4. Acceleration of atherogenesis by COX-1-dependent prostanoid formation in low density lipoprotein receptor knockout mice. Praticò D; Tillmann C; Zhang ZB; Li H; FitzGerald GA Proc Natl Acad Sci U S A; 2001 Mar; 98(6):3358-63. PubMed ID: 11248083 [TBL] [Abstract][Full Text] [Related]
5. Anti-atherogenic effect of BHB-TZD having inhibitory activities on cyclooxygenase and 5-lipoxygenase in hyperlipidemic mice. Choi JH; Jeon HJ; Park JG; Sonn SK; Lee MR; Lee MN; You HJ; Kim GY; Kim JH; Lee MH; Kwon OS; Nam KH; Kim HC; Jeong TS; Lee WS; Oh GT Atherosclerosis; 2010 Sep; 212(1):146-52. PubMed ID: 20684827 [TBL] [Abstract][Full Text] [Related]
6. Microsomal Prostaglandin E Synthase-1-Derived PGE2 Inhibits Vascular Smooth Muscle Cell Calcification. Gao C; Fu Y; Li Y; Zhang X; Zhang L; Yu F; Xu SS; Xu Q; Zhu Y; Guan Y; Wang X; Kong W Arterioscler Thromb Vasc Biol; 2016 Jan; 36(1):108-21. PubMed ID: 26543101 [TBL] [Abstract][Full Text] [Related]
7. Disruption of the 5-lipoxygenase pathway attenuates atherogenesis consequent to COX-2 deletion in mice. Yu Z; Crichton I; Tang SY; Hui Y; Ricciotti E; Levin MD; Lawson JA; Puré E; FitzGerald GA Proc Natl Acad Sci U S A; 2012 Apr; 109(17):6727-32. PubMed ID: 22493243 [TBL] [Abstract][Full Text] [Related]
9. Genetic Deletion of IL-19 (Interleukin-19) Exacerbates Atherogenesis in Ray M; Gabunia K; Vrakas CN; Herman AB; Kako F; Kelemen SE; Grisanti LA; Autieri MV Arterioscler Thromb Vasc Biol; 2018 Jun; 38(6):1297-1308. PubMed ID: 29674474 [TBL] [Abstract][Full Text] [Related]
10. Discoidin domain receptor 1 (ddr1) deletion decreases atherosclerosis by accelerating matrix accumulation and reducing inflammation in low-density lipoprotein receptor-deficient mice. Franco C; Hou G; Ahmad PJ; Fu EY; Koh L; Vogel WF; Bendeck MP Circ Res; 2008 May; 102(10):1202-11. PubMed ID: 18451340 [TBL] [Abstract][Full Text] [Related]
11. Cardiovascular Consequences of Prostanoid I Receptor Deletion in Microsomal Prostaglandin E Synthase-1-Deficient Hyperlipidemic Mice. Tang SY; Monslow J; R Grant G; Todd L; Pawelzik SC; Chen L; Lawson J; Puré E; FitzGerald GA Circulation; 2016 Jul; 134(4):328-38. PubMed ID: 27440004 [TBL] [Abstract][Full Text] [Related]
12. Atherosclerosis is attenuated by limiting superoxide generation in both macrophages and vessel wall cells. Vendrov AE; Hakim ZS; Madamanchi NR; Rojas M; Madamanchi C; Runge MS Arterioscler Thromb Vasc Biol; 2007 Dec; 27(12):2714-21. PubMed ID: 17823367 [TBL] [Abstract][Full Text] [Related]
13. Cathepsin L deficiency reduces diet-induced atherosclerosis in low-density lipoprotein receptor-knockout mice. Kitamoto S; Sukhova GK; Sun J; Yang M; Libby P; Love V; Duramad P; Sun C; Zhang Y; Yang X; Peters C; Shi GP Circulation; 2007 Apr; 115(15):2065-75. PubMed ID: 17404153 [TBL] [Abstract][Full Text] [Related]